2[2]Ikeguchi M, Tatebe S, Kaibara N, et al. Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis.Eur Surg Res,1997,29:396-402 被引量：1
3[3]Mugurmak,Nakata B, Hirkawa K, et al.p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma.Gan To Kagaku Ryoho,1998,25(suppl 3) :400-403 被引量：1
5Davidoff AM,HumphreyPA,Iglehart JD,et al.Genetic basis for p53 overexpression in human breast cancer[J].J Proc Natl Acad Sci USA,1991,88(11):5006-5010. 被引量：1
6Yoshimura R,Sano H,Masuda C,et al.Expression of cyclooxygenase-2 in prostate carcinoma[J].Cancer,2000,89(3):589-596. 被引量：1
7Smith WL,Garavito RM,Dewitt DL,et al.Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2[J].J Biol chem,1996,271(52):33157-33160. 被引量：1
8Lu CD,Altieri DC,Tanigawa N.Expression of a novel antiapoptosis gene,Survivin,correlated with tumor cell apoptosis and p53 accumulation in gastric carcinoma[J].Cancer Res,1998,58(9):1808-1812. 被引量：1
9Weinstein RS,Kusyak JR,Kluskens LF,et al.P-glycoprotein in pathology:the multidrug resistance gene family in humans[J].Hum Pathol,1990,21(1):24-27. 被引量：1
10Nguyen KT,Lin B,Ueda K,et al.Transactivation of the human multidrug resistance (MDR)gene promoter by p53 multants[J].Oncol Res,1994,6(2):71-74. 被引量：1
